Beta Cell Therapies for Preventing Type 1 Diabetes: From Bench to Bedside

Type 1 diabetes (T1D) is a chronic metabolic disease characterized by insulin deficiency, generally resulting from progressive autoimmune-mediated destruction of pancreatic beta cells. While the phenomenon of beta cell autoimmunity continues to be an active area of investigation, recent evidence sug...

Descripción completa

Detalles Bibliográficos
Autores principales: Brawerman, Gabriel, Thompson, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765619/
https://www.ncbi.nlm.nih.gov/pubmed/33339173
http://dx.doi.org/10.3390/biom10121681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765619/
https://www.ncbi.nlm.nih.gov/pubmed/33339173
http://dx.doi.org/10.3390/biom10121681

Ejemplares similares